Loading...
Patient-centred outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rupacarib maintenance treatment in patients with recurrent ovarian carcinoma
Bedel, D Lorusso, D Aghajanian, C Oaknin, A Dean, A Colombo, N Weberpals, JI Clamp, Andrew R Scambia, G Leary, A
Bedel, D
Lorusso, D
Aghajanian, C
Oaknin, A
Dean, A
Colombo, N
Weberpals, JI
Clamp, Andrew R
Scambia, G
Leary, A
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Bedel DJ, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, et al. Pcn295 Patient-centred outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rupacarib maintenance treatment in patients with recurrent ovarian carcinoma. Value Health. 2019;22:S112.